Does Rallies show Form 4 insider transactions for XNCR?

Yes. Rallies tracks XNCR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is XNCR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XNCR. It does not provide personalized investment advice.

XNCR (Xencor, Inc.) Stock Analysis - Insider Trades

Xencor, Inc. (XNCR) is a publicly traded Healthcare sector company. As of May 21, 2026, XNCR trades at $11.36 with a market cap of $820.01M and a P/E ratio of -4.86. XNCR moved +8.79% today. Year to date, XNCR is -20.67%; over the trailing twelve months it is +39.07%. Its 52-week range spans $6.92 to $27.24. Analyst consensus is strong buy with an average price target of $26.00. Rallies surfaces XNCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XNCR stock inside the company?

Recent XNCR insider activity includes Cornelissen Bart Jan sold 3.50K, Desjarlais John R sold 2.50K, Eckert Celia sold 1.77K, Dahiyat Bassil I sold 6.61K, and Desjarlais John R sold 4.12K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

XNCR Key Metrics

Key financial metrics for XNCR
Metric	Value
Price	$11.36
Market Cap	$820.01M
P/E Ratio	-4.86
EPS	$-2.29
Dividend Yield	0.00%
52-Week High	$27.24
52-Week Low	$6.92
Volume	449
Avg Volume	0
Revenue (TTM)	$97.36M
Net Income	$-172.42M
Gross Margin	0.00%

Recent XNCR Insider Trades

Cornelissen Bart Jan sold 3.50K (~$42.99K) on Apr 10, 2026.
Desjarlais John R sold 2.50K (~$27.57K) on Mar 6, 2026.
Eckert Celia sold 1.77K (~$19.47K) on Mar 6, 2026.
Dahiyat Bassil I sold 6.61K (~$72.80K) on Mar 6, 2026.
Desjarlais John R sold 4.12K (~$46.31K) on Mar 5, 2026.

Latest XNCR News

Xencor’s XmAb942 Phase 1 Yields >99% TL1A Inhibition, Phase 2b on Track — May 4, 2026
Xencor Cuts 2026 Cash Outlook by $20M–$30M After Royalties Dispute — Mar 5, 2026
Xencor Narrows Q4 Loss to $0.09, Revenue Beats by 30.6% — Feb 26, 2026

XNCR Analyst Consensus

12 analysts cover XNCR: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.00.

Common questions about XNCR

Who is trading XNCR stock inside the company?: Recent XNCR insider activity includes Cornelissen Bart Jan sold 3.50K, Desjarlais John R sold 2.50K, Eckert Celia sold 1.77K, Dahiyat Bassil I sold 6.61K, and Desjarlais John R sold 4.12K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for XNCR?: Yes. Rallies tracks XNCR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XNCR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XNCR. It does not provide personalized investment advice.